EverHint – Dip Bounce V2 (Reclaim) – Top 4 Signals for Nov 13, 2026
Excerpt: 4 signals. Healthcare leads (1). price range $100-$642. 1 with insider selling.
What This Signal Is
Production-ready dip-bounce strategy using reclaim pattern with Phase 2 market regime filters. Improved win rate from 40.42% (V1) to 50.18% (V2) with VIX and record high filters.
Entry Criteria:
- Minimum dip: 3.3% (open to intraday low)
- Minimum bounce: 1.0% from low
- Net change range: -2.0% to +0.3%
- Price above SMA(200)
- Minimum ADV: $40M
Holding period: 1-5 days | Risk level: Medium
Market Context
The mixed market picture on November 13, 2026 reveals a subtle but meaningful divergence between large-cap value and growth segments. The Dow's marginal gain contrasts with meaningful declines in the S&P 500 and Nasdaq, suggesting that risk appetite is cooling at the growth end of the spectrum while more defensive positioning holds up. For dip-bounce reclaim strategies, this environment is constructive — pullbacks in growth-oriented names are creating the technical setups these signals are designed to capture, provided the broader trend remains intact rather than rolling over into sustained distribution.
Volatility, as measured by the VIX at roughly 19 and rising, sits in a zone that tends to amplify intraday price swings without crossing into the elevated fear territory that would undermine bounce setups entirely. This moderate volatility level is a reasonable backdrop for reclaim signals — enough movement to generate meaningful entry opportunities and reward-to-risk ratios, but not so elevated that stop-outs become excessive. Traders should remain attentive to intraday whipsaws, sizing positions accordingly to account for wider-than-average price ranges.
Healthcare's emergence as the top sector for today's signals aligns well with the current rotation dynamic. As growth names face selling pressure, capital tends to migrate toward defensive and counter-cyclical sectors, and Healthcare historically benefits from this pattern. Dip-bounce setups within this sector carry an added tailwind — sector-level buying interest can support reclaim attempts even when broader market sentiment is cautious, improving the probability that technical levels hold and signals follow through.
📊 Signals (4 of 4 total)
Ranked by dip magnitude (highest first)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | MOH | Molina Healthcare, Inc. | Healthcare | $209.49 | 0.24 | — | $10.9B |
| 2 | META | Meta Platforms, Inc. | Communication Services | $641.69 | 0.19 | Sell -$257,460 | $1640.7B |
| 3 | ZM | Zoom Communications, Inc. | Technology | $99.80 | 0.12 | — | $29.1B |
| 4 | KB | KB Financial Group Inc. | Financial Services | $117.42 | 0.10 | — | $41.5B |
Recent Headlines
META (Meta Platforms, Inc.)
- Nov. 25 Could Be a Huge Day for the Stock Market
- Meta tests secret prediction-market app where users would guess for ‘cred' — not money
- Meta employees test prediction-market app, WSJ reports
- Meta Testing New Prediction-Market App With Employees
- Meta tests prediction-market app for employees, WSJ reports
- Meta Employees Are Testing Prediction-Market App - WSJ
- Qualcomm’s CEO Says Chipmakers Are in an “Extreme Shortage”
- Meta's TikTok Threat Just Became Bigger Than Oracle
- AMD’s Path to $700 Just Got Much Easier as Enterprise and Hyperscaler Diversification Tailwinds Rise
- Microsoft vs. Meta: enterprise AI distribution against monetization speed
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.